Express Pharma

Syngene opens R&D centre in Genome Valley, Hyderabad

0 2,115

The centre, located in Genome Valley, is spread across 52000 sq ft with an initial strength of around 150 scientists

Syngene International announced the commissioning of the first phase of its new R&D centre in Hyderabad. The centre, located in Genome Valley, is spread across 52000 sq ft with an initial strength of around 150 scientists. This is the company’s first operational research centre outside Bengaluru. When fully commissioned by the end of this year at an investment of Rs 167 crore, it will cover a total of 94000 sq ft and house around 270 scientists.

The centre was inaugurated by KT Rama Rao, Minister for Industries, IT, MA & UD, Government of Telangana, in the presence of Jayesh Ranjan, Principal Secretary, Industries and Commerce, Government of Telangana and Shakthi Nagappan, Director, Life Sciences & Pharma and CEO, Hyderabad Pharma City, together with senior leaders from Syngene.

Speaking on the occasion, Rao said, “We are happy that Syngene International has selected Telangana for setting up their new R&D centre This is a testimony to one of the accomplishments of BioAsia which has been able to showcase the immense potential, opportunity, and support the state offers. We have been focussing on the life sciences sector and the Genome Valley was conceptualised to provide all the necessary infrastructure and support systems for life science R&D activities. Syngene’s presence is surely a boost for the state’s vision to be a biotech hub.”

Kiran Mazumdar Shaw, MD, Syngene International said, “We are delighted to set up our new R&D centre in Genome Valley, Telan